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PPARc agonistic activityAbstract Acalypha is an important genus of the Euphorbiaceae family. The genus is represented by
five species in Saudi Arabia. Acalypha fruticosa Forssk. Fl. Aeg is traditionally used as a cure for
stomachache, dyspepsia, rheumatism, dermatitis, and swellings of the body. The present study
endeavors to provide a phytochemical and biological evaluation of the plant, with the aim of relat-
ing activity to constituting secondary metabolites in the plant. Column chromatographic separation
of the methanol extract led to the isolation of four compounds namely 2-methyl-5,7-
dihydroxychromone 5-O-b-D-glucopyranoside 1, acalyphin 2, apigenin 3 and kaempferol 3-O-
rutinoside 4. The plant extracts and the isolated compounds were subjected to biological assays
to screen peroxisome proliferator-activated receptor alpha (PPARa) and PPARc agonistic, anti-
inflammatory and cytotoxic activities. Results proved for the first time, the PPARc activator effect
of acalyphin, as well as its promising anti-inflammatory activity, in addition to the dual PPAR acti-
vator effect of the chromone glucoside. The plant extracts and isolated compounds were non-
cytotoxic to the tested cell lines. Thus A. fruticosa could be a valuable source of important thera-
peutics that may hold clinical prospect.
 2016 The Authors. Production and Hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Medical
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Acalypha is the fourth largest genus of the Euphorbiaceae family.
It consists of 450 species, in the form of evergreen shrubs, trees
and annuals, mainly in the tropical regions of Africa, America
andAsia (Seebaluck et al., 2015).The genus is represented by five
species in Saudi Arabia (Alfarhan et al., 2005). Most of the
Acalypha species are used asmedicinal plants.Acalypha fruticosa
Forssk. Fl. Aeg is an erect shrub, up to 1 m tall, with strong aro-
matic odor. It has various traditional uses, a cure for stom-
achache, dyspepsia, venom antidote, rheumatism and
dermatitis (Senthilkumar et al., 2006; Mothana et al., 2010).
Additionally, the leaf infusion is used to treat stomach problems
and swellings of the body, while the leaf maceration is applied in
eye infections and its decoction is consumed in Tanzania to treat
epilepsy (Gopalakrishnan et al., 2010). Previous studies on A.
fruticosa indicated the presence of triterpenoids, steroids,
tannins, saponins, flavonoids, alkaloids, anthraquinones
and sugars. 1, 2-Benzenedicarboxylic acid diisooctyl ester,
n-Hexadecanoic acid, 9, 12-octadecadienoic acid [z,z],
a-D-glucopyranoside and eicosyltrichlorosilane were identified
by Gas Chromatography-Mass spectrometry [GC–MS] analysis
of the plant extracts (Gopalakrishnan et al., 2010). The plant has
also been subjected to several biological investigations, concern-
ing its antioxidant, anti-inflammatory, wound healing and cyto-
toxic properties (Gopalakrishnan et al., 2010; Rajkumar et al.,
2010). A. fruticosa is also used as sand fly repellent, and used in
ethnoveterinary practices, as it demonstrates similar medicinal
properties in both humans and animals (Seebaluck et al., 2015).
The metabolic syndrome is currently a major worldwide
epidemic. It strongly associates with obesity, insulin resistance,
type 2 diabetes, and cardiovascular diseases, which are major
pathologies contributing to mortality and morbidity world-
wide (Wang et al., 2014). People affected by the metabolic syn-
drome have a greater risk of developing cardiovascular
diseases and type 2 diabetes. Peroxisome proliferator-
activated receptors (PPARs) belong to a subfamily of the
nuclear receptor super family of ligand-inducible transcription
factors, and upon activation, they are able to redirect metabo-
lism. Agonists of the nuclear receptor peroxisome proliferator-
activated receptor gamma (PPARc) are therapeutically used to
treat hyperglycemia associated with the metabolic syndrome
and type 2 diabetes. PPARa is highly expressed in muscles,
liver, heart, and kidney, and mainly regulates genes involved
in the metabolism of lipids and lipoproteins. A significant
research effort has recently been done to explore the PPARs-
activating potential of a wide range of natural products iso-
lated from traditionally used medicinal plants (Wang et al.,
2014). In the present study, a phytochemical investigation of
the methanol extract as well as a detailed biological investiga-
tion (including the PPARa, PPARc agonistic, antioxidant,
anti-inflammatory and cytotoxic activities) of the Saudi A. fru-
ticosa has been done to verify some of its traditional uses and
try to relate activities to the isolated compounds.
2. Materials and methods
2.1. General experimental procedures
The 1D and 2D NMR spectra were recorded on a Bruker
AMX-500 spectrometer with tetramethylsilane (TMS) as anPlease cite this article in press as: Fawzy, G.A. et al., Bioactivity and chemical chara
maceutical Journal (2016), http://dx.doi.org/10.1016/j.jsps.2016.05.004internal standard. The chemical shifts are in ppm (d), relative
to tetramethylsilane as an internal standard and scalar cou-
pling constants (J) recorded in Hertz. ESI-MS analyses were
measured on an Agilent Triple Quadrupole 6410 QQQ
LC/MS mass spectrometer with ESI ion source (gas tempera-
ture is 350 C, nebulizer pressure is 60 psi and gas flow rate
is 12 L/min), operating in the negative and positive scan modes
of ionization through direct infusion method using
CH3OH∖H2O (1:1 v/v), flow rate of 0.4 mL/min. Column
chromatography was carried out on Sephadex LH-20
(E. Merck, Darmstadt, Germany), silica gel (Sigma-Aldrich,
St. Louis, MO, USA). Thin layer chromatography (TLC)
was performed on precoated TLC plates (Aluminum sheets,
silica gel, RP-18 F254, Merck, Germany); the detection was
done at 254 nm and by spraying with ceric sulfate reagent.
Solvent systems used were S1 (CHCl3/MeOH 7:3), S2
(EtOAc/MeOH/dil ammonia 8:2:2) on silica gel plates and
S3 (50% aqueous MeOH) on silica gel RP-18 plates.
2.2. Plant material
The aerial parts of A. fruticosa (1.1 kg) were collected from
Southwestern region, Saudi Arabia (Jabal Shada al-A‘la) in
February, 2013. The plant was identified by Dr. Mohammed
Yusuf, Professor of Taxonomy, College of Pharmacy, King
Saud University. A voucher specimen (No. 16018) has been
deposited in the herbarium of Department of Pharmacognosy,
King Saud University.
2.3. Extraction and isolation
The aerial parts of A. fruticosa (1.1 kg) were shade-dried,
ground and successively extracted at room temperature with
chloroform (3  2.5 L) and methanol (4  2.5 L). A part of
the methanol extract (50 g) was dissolved in water and loaded
on Sephadex LH-20 column (5  120 cm, 500 g), and the elu-
tion started with water followed by H2O/MeOH gradient mix-
tures till 100% MeOH, to afford three main sub-fractions.
Fraction M-I (1.5 g, eluted by 30% MeOH/Water), was
rechromatographed on a silica gel column (2  100 cm,
100 g), elution started with 7% MeOH/CHCl3 to afford com-
pounds 1 (12% MeOH/CHCl3) (40 mg) and 2 (15% MeOH/
CHCl3) (10 mg). Sub-fraction M-II (0.5 g, eluted by 40%
MeOH/Water), was chromatographed on silica gel
(2  100 cm, 80 g), in 10% MeOH/CHCl3, to afford com-
pound 3 (12 mg). Sub-fraction M-III (1.3 g, eluted by 45%
MeOH/Water), was chromatographed on silica gel
(2  100 cm, 100 g), in 10% MeOH/CHCl3, to afford com-
pound 4 (30 mg) (in 15% MeOH/CHCl3).
2.4. Characterization of isolated compounds
2-methyl-5,7-dihydroxychromone 5-O-b-D-glucopyranoside (1):
white needles, mp 162–163 C, violet color on TLC under
UV-light (254 nm); 1H NMR (MeOD) d: 6.77 (1H, d,
J= 2 Hz, H-6), 6.51 (1H, d, J= 2 Hz, H-8), 6.01 (1H, s, H-
3), 4.82 (1H, d, J= 8 Hz, H-1‘), sugar protons H20–H60, at d
3.98–3.32, 2.33 (3H, s, Me), 13C NMR (MeOD) d: 178.8 (C-
4), 165.7 (C-7), 163.1 (C-8a), 159.5 (C-2), 158.6 (C-5), 110.2
(C-3), 107.7 (C-4a), 103.6 (C-6), 103.2 (C-8), 97.7 (C-10), 77.2
(C-30), 75.8 (C-50), 73.3 (C-20), 69.8 (C-40), 61.1 (C-60), 18.5cterization of Acalypha fruticosa Forssk. growing in Saudi Arabia. Saudi Phar-
Bioactive constituents of Acalypha fruticosa 3(Me-2). 1H and 13C NMR data were consistent with other lit-
erature; molecular ion peak m/z 354 [M]+ corresponding to
the molecular formula C16H18O9 (Tane et al., 1990).
Acalyphin (2): white powder, Dragendorff-positive spot on
TLC; 1H NMR (MeOD) d: 5.41 (1H, s, H-3), 5.30 (1H, s, H-6),
3.02 (3H, s, N–CH3), 3.85 (3H, s, O–CH3), 4.75 (1H, d,
J= 7.5 Hz, H-10), 3.20–3.80 (m, H20–H60). 13C NMR (MeOD)
d: 164.5 (C-6), 159.2 (C-4), 115.2 (–CN), 103.1 (C-10), 96.9 (C-
5), 84.5 (C-2), 78.6 (C-3), 78.3 (C-50), 77.7 (C-30), 74.4 (C-20),
71.1 (C-40), 62.5 (C-60), 56.8 (O–CH3), 32.9 (N–CH3); molecu-
lar ion peak m/z 360.3, [M]+, neg.mod., m/z: 359.2 [MH]
(Nahrstedt et al., 1982).
Apigenin (3): pale yellow amorphous powder, pale yellow
fluorescence (AlCl3) under UV-light (365 nm) and green color
with FeCl3 spray reagents.
1H NMR (MeOD) d: 7.48 (2H, d,
J= 8.5 Hz, H-20/60), 6.83 (2H, d, J= 8.5 Hz, H-30/50), 6.33
(1H, d, J= 2.5 Hz, H-8), 6.20 (1H, d, J= 2.5 Hz, H-6), 6.01
(1H, s, H-3). Negative ESI-MS: m/z= 269.2 [MH]
(Mabry et al., 1970; Williams and Harborne, 1994).
Kaempferol 3-O-rutinoside (4): yellow amorphous powder,
complete acid hydrolysis products: kaempferol (organic
phase); D-glucose and L- rhamnose (aqueous phase). 1H
NMR (MeOD) d: 8.07 (2H, d, J= 8 Hz, H-20/60), 6.92 (2H,
d, J= 8 Hz, H-30/50), 6.40 (1H, brs, H-8), 6.20 (1H, brs, H-
6), 5.46 (1H, d, J= 7.5 Hz, H-100), 4.53 (1H, brs, H-1000),
3.83–3.23 (m, H200–H600, H2000–H5000), 1.11 (3H, d, J= 6 Hz,
CH3-6
000). 13C NMR (MeOD) d: 179.3 (C-4), 165.7 (C-7),
159.0 (C-5), 158.4 (C-2/9), 148.8 (C-40), 134.7 (C-3), 132.4
(C-20/60), 132.3, 123.2 (C-10), 116.3 (C-30/50), 105.9 (C-10),
102.2 (C-1000), 100.9 (C-100), 99.9 (C-6), 94.9 (C-8), 78.5 (C-
300), 76.9 (C-500), 75.6 (C-200), 73.9 (C-4000), 72.3 (C-3000), 71.9
(C-2000), 71.2 (C-400), 69.7 (C-5000), 68.4 (C-600), 18.0 (C-6000).
Negative ESI-MS, m/z 593.1 [MH] and 285.3
[kaempferolH] (Nahrstedt et al., 2006).
2.5. Acetylation of compound 1 (1a)
Compound 1 (20 mg) was dissolved in pyridine-acetic anhy-
dride (1:1, 2 mL) and stirred overnight at room temperature.
The mixture was evaporated to dryness using rotary evapora-
tor in vacuum under N2 which gave a pentaacetate derivative
as white amorphous powder.
2.6. Acid hydrolysis of compounds 1 and 4
A solution of 5 mg in 10 ml MeOH–1N HCl (1:1) was boiled
under reflux for 4 h, concentrated under reduced pressure and
diluted with H2O (10 ml). It was extracted with EtOAc and
the residue recovered from the organic phase yielded the agly-
cone. The remaining aqueous layer was neutralized with 5%
aq.NaHCO3 solution and concentrated under vacuum and then
the sugars were identified by comparative TLC (EtOAc/MeOH/
H2O/HOAc, 12:3:3:4) with authentic standards.
2.7. Biological study
2.7.1. PPARa and PPARc activation
The activation of PPARa and PPARc was determined through
a reporter gene assay in HepG2 cells transfected with pSG5-
PPARa and PPRE X3-tk-luc or pCMV-rPPARc and
pPPREaP2-tk-luc plasmids as reported earlier (Zhao et al.,Please cite this article in press as: Fawzy, G.A. et al., Bioactivity and chemical chara
maceutical Journal (2016), http://dx.doi.org/10.1016/j.jsps.2016.05.0042014). Transfected cells were seeded in 96-well plates at a den-
sity of 5  104 cells/well and after 24 h of incubation; the cells
were exposed to various concentrations of test samples. After
an incubation of 24 h luciferase activity was measured and fold
increase in luciferase activity in sample treated cells was calcu-
lated in comparison with vehicle treated cells. Ciprofibrate and
rosiglitazone were included as drug controls in each assay.
2.7.2. Inhibition of cellular oxidative stress
The cellular antioxidant activity was measured in HepG2 cells
according to the method of Wolfe and Liu (2007) as described
earlier (Al-Taweel et al., 2015). In this assay the ability of test
samples to prevent intracellular generation of peroxyl radicals
in response to ABAP[2,20-azobis (2-amidinopropane) dihy-
drochloride] is determined. The method is more biologically rel-
evant than a chemical method. HepG2 cells were seeded at a cell
density of 60,000 cells/well and plates were incubated for 24 h.
After washing with PBS cells were treated with the test samples
(diluted inmedium containing 25 lMDCFH-DA) for 1 h.After
removing the medium containing samples, ABAP (600 lM)was
added to each well and plate was immediately read on a
SpectraMax plate reader every 5 min for 1 h (37 C, emission
and excitation at 538 nm and 485 nm, respectively). Quercetin
was included as the positive control. Antioxidant activity was
calculated in terms of percent decrease in oxidative stress.
% decrease in oxidative stress ¼ 100
 ½ðAUC sample=AUC controlÞ  100:2.7.3. Inhibition of iNOS activity
Mouse macrophage cell line (RAW264.7) was seeded in the
wells of 96-well plates at a density of 50,000 cells/well and
grown for 24 h for a confluency of >75%. Cells were exposed
to various dilutions of test samples for 30 min before adding
lipopolysaccharides (LPS, 5 lg/mL) and incubating for 24 h.
Nitric oxide (NO) level in the cell supernatant was determined
by Griess reagent. The inhibition of NO production by the
sample was calculated in comparison with vehicle control.
IC50 values were obtained from dose curves. Parthenolide
(Sigma-Aldrich, St Louis, MO, USA) was used as positive con-
trol (Zhao et al., 2014; Al-Taweel et al., 2015).
2.7.4. Inhibition of NF-kB activity
Human chondrosarcoma cells transfected with NF-kB lucifer-
ase plasmid construct were plated in 96-well plates at a density
of 1.25  105 cells per well. After 24 h incubation, cells were
treated with various dilutions of test samples for 30 min and
then induced with PMA (70 ng/mL) for 8 h. Luciferase activity
was measured using a Luciferase Assay Kit (Promega, Madi-
son, WI, USA). The inhibition of NF-kB activity was calcu-
lated in terms of decrease in luciferase expression. IC50
values were obtained from the dose curves. Parthenolide was
included as positive control (Zhao et al., 2014; Al-Taweel
et al., 2015).
2.7.5. Cytotoxicity
Cytotoxic activity of the samples was determined against a
panel of four human cancer cell lines (SK-MEL, KB, BT-
549, SK-OV-3) and two noncancerous kidney cell lines
(LLC-PK1 and VERO) as described earlier (Al-Taweel et al.,cterization of Acalypha fruticosa Forssk. growing in Saudi Arabia. Saudi Phar-
Figure 1 Structures of compounds 1–4.
4 G.A. Fawzy et al.2015). All cell lines were obtained from the American Type
Culture Collection (ATCC, Rockville, MD). Cells at a density
of 25,000 cells/well were grown for 24 h for confluency before
adding the test samples and incubating further for 48 h. The
cell viability was measured by Neutral Red assay according
to the procedure of Borenfreund et al. (1990). Doxorubicin
was used as a positive control, while DMSO was used as the
negative (vehicle) control.
3. Results
The methanol extract of the aerial parts of A. fruticosa was
subjected to a series of column chromatographic separations
to obtain four compounds namely, 2-methyl-5,7-
dihydroxychromone 5-O-b-D-glucopyranoside 1 (new in genus
Acalypha), acalyphin 2 (new in the species A. fruticosa),
apigenin 3 (new in genus Acalypha) and Kaempferol 3-O-
rutinoside 4 (new in the species A. fruticosa) (Fig. 1). The struc-
tures of the isolated compounds were established by MS and
NMR spectroscopy. The four isolated compounds as well as
the acetylated chromone glucoside 1a, were subjected to the
biological investigation.
3.1. PPARa and PPARc agonistic activity
The chloroform and methanol extracts as well as the isolated
compounds were investigated for their PPARa and PPARc
agonistic activity with results shown in Table 1. Fold induction
in the activity of PPAR was determined in response to the
extract or compound in comparison with untreated controls.
A fold induction of 1.5 means a 50% increase in PPAR activa-
tion. Dual activator effect was given by the chloroform extract,
compounds 1, 1 a and 4. The methanol extract did not show
any PPAR agonistic activity, while compound 2 revealed
promising PPAR c specific agonistic activity (2.45), and 3
was PPARa specific with weak activity, compared to Rosigli-
tazone and Ciprofibrate 10 lM respectively.
3.2. Inhibition of cellular oxidative stress, iNOS and NF-kB
activities
The methanol extract of A. fruticosa aerial parts showed a
decrease in cellular oxidative stress (36% decrease at
1000 lg/mL) but did not show any inhibition of NF-kB and
iNOS activities (Table 2). As for the isolated compounds, 1
and its acetylated derivative 1a, were the most effective in
decreasing oxidative stress with 51% and 25% decrease respec-
tively, at 250 lg/mL.
All compounds showed promising NF-kB inhibitory activ-
ity, except 4. Acalyphin 2, was the most active among the
tested compounds by inhibiting the NF-kB activity with IC50
values of 3.9 lg/mL, compared to parthenolide (0.5 lgmL) as
positive control. The inhibition of NF-kB by 1, 1a and 3 was
almost similar. Interestingly 1a (acetylated form of 1) showed
iNOS inhibition while 1 did not. Acalyphin 2 was the most
active in inhibiting iNOS with IC50 of 15.5 lg/mL.
3.3. Cytotoxic activity
Cytotoxic activity of the samples was determined against a
panel of four human cancer cell lines (SK-MEL, KB,Please cite this article in press as: Fawzy, G.A. et al., Bioactivity and chemical chara
maceutical Journal (2016), http://dx.doi.org/10.1016/j.jsps.2016.05.004BT-549, SK-OV-3) and two non-cancerous kidney cell lines
(LLC-PK1 and VERO). The extracts and the isolated com-
pounds were not cytotoxic to any of the tested cell lines up
to 100 lg/mL (data not shown).4. Discussion
This study represents the first report on isolation of bioactive
metabolites from Saudi A. fruticosa. Great research efforts
have recently been undertaken to explore the potential of selec-
tive PPARc modulators (SPPARMs), compounds that
improve glucose homeostasis but elicit reduced side effects
due to partial PPARc agonism based on selective receptor-
cofactor interactions and target gene regulation (Wang et al.,
2014). From the study, it was proved that acalyphin (2)
revealed promising PPAR c specific agonistic activity and api-
genin (3) possessed weak PPARa specific agonistic activity,
compared to Rosiglitazone and Ciprofibrate 10 lM respec-
tively. Based on our findings, it is recommended to further
investigate the PPARc agonistic potential of acalyphin (2). It
is worth noting that the acetylation of the chromone glucoside
(1) increased the PPARa activator effect of 1a. Apigenin (3)cterization of Acalypha fruticosa Forssk. growing in Saudi Arabia. Saudi Phar-
Table 1 PPAR agonistic activity of A. fruticosa extracts and isolated compounds.
Sample name Fold induction
PPAR alpha PPAR gamma
50 lg/ml 25 lg/ml 12.5 lg/ml 50 lg/ml 25 lg/ml 12.5 lg/ml
Chloroform extract 1.67 ± 0.15 1.48 ± 0.21 1.36 ± 0.18 1.6 ± 0.08 1.48 ± 0.07 1.39 ± 0.18
Methanol extract NA NA NA NA NA NA
1 1.16 ± 0.16 1.64 ± 0.07 1.28 ± 0.36 1.65 ± 0.12 1.39 ± 0.33 1.22 ± 0.11
1a 2.25 ± 0.26 1.41 ± 0.40 1.44 ± 0.08 1.56 ± 0.77 1.54 ± 0.73 1.16 ± 0.01
2 NA NA NA 1.06 ± 0.06 2.45 ± 0.40 1.83 ± 0.03
3 1.46 ± 0.38 1.42 ± 0.10 0.93 ± 0.05 NA NA NA
4 1.53 ± 0.06 1.27 ± 0.50 0.81 ± 0.13 2.31 ± 0.60 1.56 ± 0.30 1.26 ± 0.08
Ciprofibrate 10 lM 2.2 ± 0.21 NT
Rosiglitazone 10 lM NT 4.33 ± 0.54
NA= no activity, NT = not tested.
Table 2 Anti-inflammatory activity of A. fruticosa extracts and isolated compounds.
aSample Name % decrease in oxidative stress Inhibition of NF-kB activity IC50 in lg/mL Inhibition of iNOS activity IC50 in lg/mL
Chloroform
extract
29 NA NA
Methanol extract 36 NA NA
1 51 29.5 ± 6.5 NA
1a 25 24.5 ± 2.5 35 ± 5.0
2 NA 3.9 ± 2.1 15.5 ± 1.5
3 NA 17.0 ± 1.0 >50
4 NA >100 NA
Parthenolideb – 0.5 ± 0.10 0.3 ± 0.07
Quercetinb 76 ± 2.4 – –
a At 1000 lg/ml for fraction and 250 lg/ml for pure compound.
b Positive control NA= no activity up to 100 lg/mL.
Bioactive constituents of Acalypha fruticosa 5only showed PPARa agonistic activity, whereas literature
proved the PPARc agonistic action of luteolin, a structurally
related flavone. Additionally, the activity of kaempferol ruti-
noside (4) is in agreement with the literature on PPARc activ-
ity of kaempferol aglycone (Wang et al., 2014). The methanol
extract did not show any PPAR agonistic activity, which
indicates the possible antagonistic action of the constituting
compounds. This could be considered as the first report on
the PPAR agonistic activity of A. fruticosa extracts and iso-
lated compounds. A previous study on A. fruticosa proved
the hypoglycemic activity of its aqueous extract (El-Shaibany
et al., 2015).
The methanol extract of A. fruticosa aerial parts showed
antioxidant potential which could be attributed mainly to the
chromone glucoside (1). The replacement of the hydroxyl
groups with acetyl groups in 1a, seemed to decrease the antiox-
idant potential of the chromone glucoside (1).
The data shown in Table 2, indicate that anti-inflammatory
properties of 1, 1a and 2 could be explained in terms of the
inhibition of NF-kB transcriptional activity and inhibition of
iNOS. The results are also in agreement with the previously
reported anti-inflammatory effects of acalyphin (Nirmal
et al., 2008), chromone glucosides (Xue et al., 2000), and api-
genin (Funakoshi-Tago et al., 2011). However, the chloroform
and methanol extracts of the Saudi A. fruticosa species did not
show anti-inflammatory activity, probably implying thePlease cite this article in press as: Fawzy, G.A. et al., Bioactivity and chemical chara
maceutical Journal (2016), http://dx.doi.org/10.1016/j.jsps.2016.05.004antagonistic action of various constituents present in them.
This is also in contrary to previous literature reporting the
anti-inflammatory activity of the methanolic extract of the
leaves of A. fruticosa (Gupta et al., 2004), which could be
explained in terms of the differences in the composition of
the two extracts and the mechanism of action responsible for
anti-inflammatory activity.
Concerning the cytotoxic activity, the extracts and the iso-
lated compounds were not cytotoxic to any of the tested cell
lines up to 100 lg/mL (data not shown). This is in agreement
with the literature, which showed a weak anticancer activity
of the A. fruticosa methanol extract (Mothana et al., 2007;
Rajkumar et al., 2010).5. Conclusion
In summary, this work represents the first detailed phytochem-
ical and biological investigation of the Saudi A. fruticosa. The
chloroform, methanol extracts and the four isolated com-
pounds were subjected to PPAR agonistic, anti-inflammatory
and cytotoxic activity evaluation. The results revealed the
promising PPAR c specific agonistic activity of acalyphin, as
well as its significant anti-inflammatory activity among the
tested compounds. It also proved the non-cytotoxic nature of
the extracts and the isolated compounds.cterization of Acalypha fruticosa Forssk. growing in Saudi Arabia. Saudi Phar-
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